Source link : https://www.newshealth.biz/health-news/teclistamab-shows-promise-in-refractory-autoimmune-diseases/
TOPLINE: Teclistamab, a T-cell engager that targets B-cell maturation antigen (BCMA), improved disease activity in four patients with refractory autoimmune conditions. In a separately published case report, teclistamab treatment induced remission in a patient with refractory systemic lupus erythematosus (SLE). BACKGROUND: Chimeric antigen receptor (CAR) T cells or T-cell engagers against CD19 have been effective […]
Author : News Health
Publish date : 2024-09-04 21:01:38
Copyright for syndicated content belongs to the linked Source.